125 related articles for article (PubMed ID: 12078026)
1. [Interferon-induced paranoid psychosis. Review of the literature and case report].
Kornischka J; Burtscheidt W; Gaebel W
Nervenarzt; 2002 May; 73(5):463-7. PubMed ID: 12078026
[TBL] [Abstract][Full Text] [Related]
2. Paranoid psychosis and cognitive impairment associated with hepatitis C antiviral therapy.
Budhram A; Cebrian C
Gen Hosp Psychiatry; 2014; 36(1):126.e3-5. PubMed ID: 24210465
[TBL] [Abstract][Full Text] [Related]
3. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.
Manjón-Haces JA; Vázquez-López F; Gómez-Díez S; Hidalgo-García A; Pérez-Alvarez R; Soler-Sánchez T; Pérez-Oliva N
Acta Derm Venereol; 2001; 81(3):223. PubMed ID: 11558891
[No Abstract] [Full Text] [Related]
4. Side effects of therapy for chronic hepatitis C.
Russo MW; Fried MW
Gastroenterology; 2003 May; 124(6):1711-9. PubMed ID: 12761728
[No Abstract] [Full Text] [Related]
5. Summaries for patients. Duration and dose of antiviral treatment for chronic hepatitis C.
Ann Intern Med; 2004 Mar; 140(5):I67. PubMed ID: 14996694
[No Abstract] [Full Text] [Related]
6. Cutaneous reactions to interferon and ribavirin.
Chamberlain AJ; Poon E
Intern Med J; 2004 Aug; 34(8):519. PubMed ID: 15317557
[No Abstract] [Full Text] [Related]
7. [Peginterferon alfa-2b and ribavirin-induced pure red cell aplasia during treatment of chronic hepatitis C treated by cyclosporin A with good response].
Kato M; Ryu T; Miura H; Yamada H; Saito T
Nihon Naika Gakkai Zasshi; 2008 Jul; 97(7):1678-80. PubMed ID: 18681159
[No Abstract] [Full Text] [Related]
8. Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C.
Sagir A; Wettstein M; Heintges T; Häussinger D
Dig Dis Sci; 2002 Mar; 47(3):562-3. PubMed ID: 11911342
[No Abstract] [Full Text] [Related]
9. Intracerebral hemorrhage in a patient receiving combination therapy of pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
Nishiofuku M; Tsujimoto T; Matsumura Y; Toyohara M; Yoshiji H; Yamao J; Fukui H; Yoshikawa M
Intern Med; 2006; 45(7):483-4. PubMed ID: 16679707
[No Abstract] [Full Text] [Related]
10. [Side effects of interferon-based therapy for chronic hepatitis C virus infection and clinical management of them].
Iwasaki Y; Ikeda F; Yamamoto K
Nihon Rinsho; 2011 May; 69 Suppl 4():215-20. PubMed ID: 22096922
[No Abstract] [Full Text] [Related]
11. Chronic paranoid psychosis and dementia following interferon-alpha treatment of hepatitis C: a case report.
Drozdz W; Borkowska A; Wilkosc M; Halota W; Dybowska D; Rybakowski JK
Pharmacopsychiatry; 2007 Jul; 40(4):146-8. PubMed ID: 17694476
[TBL] [Abstract][Full Text] [Related]
12. [Cutaneous necrosis in patient with chronic hepatitis].
García-Morán S; Sáez-Royuela F; Muñoz Fernández-Lomana C
Rev Clin Esp; 2007 Feb; 207(2):95-6. PubMed ID: 17397573
[No Abstract] [Full Text] [Related]
13. Managing adverse effects of interferon-alfa and ribavirin in combination therapy for HCV.
Slim J; Afridi MS
Infect Dis Clin North Am; 2012 Dec; 26(4):917-29. PubMed ID: 23083824
[TBL] [Abstract][Full Text] [Related]
14. [Interferon-alpha plus ribavirin combination therapy in chronic hepatitis C].
Sarrazin C; Zeuzem S
Z Gastroenterol; 1999 Jul; 37(7):669-74. PubMed ID: 10458015
[No Abstract] [Full Text] [Related]
15. [Cutaneous sarcoidosis after treatment with interferon for hepatitis C: A not entirely rare but often overlooked reaction].
Waltschew A
Pathologe; 2016 Mar; 37(2):184-6. PubMed ID: 26769217
[TBL] [Abstract][Full Text] [Related]
16. The uncertain natural history of thyrotoxic patients treated with combination interferon alfa-2beta and ribavirin.
Tran HA
Arch Intern Med; 2005 May; 165(9):1072; author reply 1072-3. PubMed ID: 15883255
[No Abstract] [Full Text] [Related]
17. Male periconceptional ribavir-ininterferon alpha-2b exposure with no adverse fetal effects.
Bianca S; Ettore G
Birth Defects Res A Clin Mol Teratol; 2003 Jan; 67(1):77-8. PubMed ID: 12749388
[No Abstract] [Full Text] [Related]
18. [Necrotic lesion in a patient with hepatitis C virus liver disease under treatment with pegylated interferon].
Rosel L; Blanco JR; Metota L; Oteo JA
Enferm Infecc Microbiol Clin; 2004 Oct; 22(8):497-8. PubMed ID: 15482692
[No Abstract] [Full Text] [Related]
19. Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Onyike CU; Bonner JO; Lyketsos CG; Treisman GJ
Am J Psychiatry; 2004 Mar; 161(3):429-35. PubMed ID: 14992966
[No Abstract] [Full Text] [Related]
20. [Neuropsychiatric adverse events in patients with chronic hepatitis C treated with pegylated or recombinant interferon-alpha].
Drózdz W; Ziółkowska-Kochan M; Kozielewicz D; Dybowska D; Borkowska A; Halota W
Przegl Epidemiol; 2008; 62(1):93-100. PubMed ID: 18536230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
